Purchase Fragment 176-191 Online
Fragment 176-191 is a synthetic peptide that has attracted considerable interest in scientific research due to its unique properties and potential applications. As a modified form of the human growth hormone (HGH), Fragment 176-191 specifically focuses on the fat-burning segment of the HGH molecule. This comprehensive overview will explore the structural composition, mechanism of action, and key research areas associated with Fragment 176-191.
Structural Composition and Mechanism of Action
Fragment 176-191 is a peptide derived from the C-terminal region of human growth hormone, specifically the amino acid residues 176 to 191. This segment is responsible for the lipolytic (fat-reducing) activity of HGH. By isolating this specific fragment, researchers have created a peptide that targets fat metabolism without the broader effects associated with the full-length growth hormone.
The primary mechanism of action for Fragment 176-191 involves its interaction with fat cells to stimulate lipolysis, or the breakdown of fat. This peptide works by mimicking the way natural growth hormone regulates fat metabolism but does so without influencing insulin sensitivity or promoting muscle growth. This specificity makes Fragment 176-191 a valuable tool for studying fat metabolism and related processes.
Key Research Areas
- Fat Metabolism and Lipolysis: One of the primary research areas for Fragment 176-191 is its impact on fat metabolism and lipolysis. Researchers are particularly interested in how this peptide stimulates the breakdown of fat cells. Studies focus on understanding the molecular mechanisms behind this process and exploring potential applications of Fragment 176-191 in obesity and metabolic research.
- Energy Expenditure: Fragment 176-191 is also studied for its effects on energy expenditure. By influencing fat metabolism, this peptide can affect how the body utilizes and stores energy. Researchers investigate how Fragment 176-191 modulates these energy pathways, providing insights into metabolic regulation and potential therapeutic applications for metabolic disorders.
- Comparative Studies with Other Peptides: Fragment 176-191 is often compared with other peptides to evaluate its relative efficacy and selectivity. Comparative studies focus on its unique properties, such as its specific action on fat cells and minimal impact on other physiological processes. These studies help establish Fragment 176-191’s unique characteristics and potential benefits over other peptides.
- Pharmacokinetics and Bioavailability: The pharmacokinetics and bioavailability of Fragment 176-191 are also key research focuses. Researchers investigate how this peptide is absorbed, distributed, metabolized, and excreted in the body. Understanding these factors is crucial for optimizing the use of Fragment 176-191 in various research applications.
- Potential Applications in Obesity Research: Due to its specific action on fat metabolism, Fragment 176-191 is a subject of interest in obesity research. Researchers explore how this peptide can be used to study the mechanisms of fat reduction and energy balance, providing insights into potential interventions for obesity and related metabolic disorders.
Applications in Scientific Research
Fragment 176-191 is widely used in scientific research due to its specific action on fat metabolism and its ability to modulate various metabolic processes. Its applications span multiple fields, including endocrinology, metabolism, obesity research, and pharmacokinetics.
In endocrinology, Fragment 176-191 is used to study the mechanisms of hormone regulation and fat metabolism. Researchers investigate how this peptide influences fat breakdown and its effects on endocrine function, providing insights into the regulation of fat metabolism and potential therapeutic applications.
In metabolic research, Fragment 176-191’s role in regulating lipid metabolism and energy expenditure is a key focus. Studies explore how this peptide modulates these metabolic processes, offering potential applications in metabolic disorders and weight management.
In obesity research, Fragment 176-191 is utilized to explore its effects on fat reduction and energy balance. Researchers study how this peptide influences body fat composition and energy pathways, providing insights into its potential applications in obesity and metabolic disorder studies.
In pharmacokinetics, the absorption, distribution, metabolism, and excretion of Fragment 176-191 are studied to optimize its use in research settings. Understanding these factors is crucial for developing effective research methodologies involving Fragment 176-191.
Conclusion
Fragment 176-191 is a powerful synthetic peptide with significant potential in scientific research. Its ability to specifically target fat metabolism and modulate various metabolic processes makes it invaluable for studying fat reduction, energy expenditure, and metabolic regulation. As research continues, Fragment 176-191 remains a critical focus for advancing our understanding of these complex biological mechanisms and their potential applications.
| Unit Size | 5mg |
|---|---|
| Appearance | Lyophilized White Powder |
| CAS NO. | 946870-92-4 |
| Manufactured | United States |
| Synonyms | Frag 176-191 HGH Fragment |
| Molecular Weight | 1817.1 |
| Sequence | H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 |
| Storage | Fragment 176-191 is stable at room temperature for up to 90 days, long term storage requires -8 degrees Celsius for best preservation |
| Terms | The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering. |
